ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice.

Ya-Wen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.